Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | +2.12% | +2.05% | -2.31% |
Feb. 28 | Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance | MT |
Evolution of the average Target Price on Sabra Health Care REIT, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sabra Health Care REIT, Inc.
Deutsche Bank Securities | |
Mizuho Securities | |
Stifel Nicolaus | |
BMO Capital | |
Wells Fargo Securities | |
BofA Securities | |
Wedbush | |
Jefferies & Co. | |
Citigroup | |
Barclays | |
Truist Securities | |
JMP Securities | |
Baird | |
Berenberg Bank | |
Credit Suisse | |
KeyBanc Capital Markets |
EPS Revisions
- Stock Market
- Equities
- SBRA Stock
- Consensus Sabra Health Care REIT, Inc.